1. Home
  2. GRND vs ARDX Comparison

GRND vs ARDX Comparison

Compare GRND & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grindr Inc.

GRND

Grindr Inc.

HOLD

Current Price

$11.25

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.75

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRND
ARDX
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
GRND
ARDX
Price
$11.25
$5.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
$22.75
$13.75
AVG Volume (30 Days)
1.7M
3.3M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
$29.03
$35.64
Revenue Next Year
$21.87
$34.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.79
$3.50
52 Week High
$25.13
$8.40

Technical Indicators

Market Signals
Indicator
GRND
ARDX
Relative Strength Index (RSI) 51.00 28.83
Support Level $9.79 $5.47
Resistance Level $14.12 $6.23
Average True Range (ATR) 0.52 0.35
MACD 0.18 -0.22
Stochastic Oscillator 84.31 7.60

Price Performance

Historical Comparison
GRND
ARDX

About GRND Grindr Inc.

Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: